Nano-regenerative medicine towards clinical outcome of stem cell and tissue engineering in humans

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 9, 2012, Pages 1991-2000

  Arora, Pooja ^a   Sindhu, Annu ^a   Dilbaghi, Neeraj ^a   Chaudhury, Ashok ^a,c   Rajakumar, Govindasamy ^b   Rahuman, Abdul Abdul ^b  

^a GURU JAMBHESHWAR UNIVERSITY OF SCIENCE AND TECHNOLOGY   (India)

^b C ABDUL HAKEEM COLLEGE   (India)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Magnetic nanoparticles; Nanomaterials; Nanotechnology; Regenerative medicine; Stem cells; Tissue engineering

Indexed keywords

NANOMATERIAL;

ARTICLE; CHEMISTRY; CYTOLOGY; GENETIC PROCEDURES; HUMAN; METABOLISM; METHODOLOGY; NANOTECHNOLOGY; REGENERATION; REGENERATIVE MEDICINE; STEM CELL; TISSUE ENGINEERING;

BIOSENSING TECHNIQUES; HUMANS; NANOSTRUCTURES; NANOTECHNOLOGY; REGENERATION; REGENERATIVE MEDICINE; STEM CELLS; TISSUE ENGINEERING;

EID: 84865421372     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2012.01534.x     Document Type: Article

References (108)

1. Shrivastava S, Dash D. Nanotechnology in agriculture. J Nanotechnol. 2009; 184702: 1-14.
2. Engel E, Michiardi A, Navarro M, et al. Nanotechnology in regenerative medicine: the materials side. Cell Press. 2007; 26: 39-47.
3. Yang YK, Leong W. Nanoscale surfacing for regenerative medicine. WIREs Nanomed Nanobiotechnol. 2010; 2: 478-95.
4. Mimeault M, Hauke R, Batra SK. Stem cells: a revolution in therapeutics-recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies. Clin Pharmacol Ther. 2007; 2: 252-64.
5. Martin I, Wendt D, Heberer M. The role of bioreactors in tissue engineering. Trends Biotechnol. 2004; 22: 80-6.
6. Whitman DH, Berry RL, Green DM. Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg. 1997; 55: 1294-9.
7. Marx RE. Platelet rich plasma: evidence to support its use. J Oral Maxillofac Surg. 2004; 62: 489-96.
8. Porcellini A. Regenerative medicine: a review. Rev Bras Hematol Hemoter. 2009; 3: 63-6.
9. Kang X, Xie Y, Powell HM, et al. Adipogenesis of murine embryonic stem cells in a three-dimensional culture system using electrospun polymer scaffolds. Biomaterials. 2007; 28: 450-8.
10. 2 nanotube diameter directs cell fate. Nano Lett. 2007; 7: 1686-91.
11. Dalby MJ, Gadegaard N, Tare R, et al. The interaction of human bone marrow cells with nanotopographical features in three-dimensional constructs. J Biomed Mater Res. 2007; 79: 431-9.
12. Yim EKF, Pang SW, Leong KW. Synthetic nanostructures inducing differentiation of human mesenchymal stem cells into neuronal lineage. Exp Cell Res. 2007; 313: 1820-9.
13. Chua KN, Chai C, Lee PC, et al. Functional nanofiber scaffolds with different spacers modulate adhesion and expansion of cryopreserved umbilical cord blood hematopoietic stem/progenitor cells. Exp Hematol. 2007; 35: 771-81.
14. Chua KN, Chai C, Lee PC, et al. Surface-aminated electrospun nanofibers enhance adhesion and expansion of human umbilical cord blood hematopoietic stem/progenitor cells. Biomaterials. 2006; 27: 6043-51.
15. Yang F, Murugan R, Ramakrishna S, et al. Fabrication of ano-structured porous PLLA scaffold intended for nerve tissue engineering. Biomaterials. 2004; 25: 1891-900.
16. Yang F, Murugan R, Wang S, et al. Electrospinning of nano/micro scale poly(l-lactic acid) aligned fibers and their potential in neural tissue engineering. Biomaterials. 2005; 26: 2603-10.
17. Guo J, Su H, Zeng Y, et al. Reknitting the injured spinal cord by self assembling peptide nanofiber scaffold. Nanomedicine. 2007; 3: 311-21.
18. Berry CC, Dalby MJ, Oreffo ROC, et al. The interaction of human bone marrow cells with nanotopographical features in three-dimensional constructs. J Biomed Mater Res A. 2006; 79: 431-6.
19. Ferreira L, Karp JM, Nobre L, et al. New opportunities: the use of nanotechnologies to manipulate and track stem cells. Cell Stem Cell. 2008; 3: 136-46.
20. Wang Z, Ruan J, Cui D. Advances and prospect of nanotechnology in stem cells. Res Lett. 2009; 4: 593-605.
21. Chachques JC. Development of bioartificial myocardium using stem cells and nanobiotechnology templates. Car Res Prac. 2011; doi: 10.4061/2011/806795.
22. Kshitiz K, Kim DH, Beebe DJ, et al. Micro- and nanoengineering for stem cell biology: the promise with a caution Trend Biotechnol. 2011; 29: 399-408.
23. Martino S, D'Angelo F, Armentano I, et al. Stem cell-biomaterial interactions for regenerative medicine. Biotechnol Adv. 2011; doi: 10.1016/j.biotechadv.2011.06.015.
24. Chan WC, Maxwell DJ, Gao X, et al. Luminescent quantum dots for multiplexed biological detection and imaging. Curr Opin Biotechnol. 2002; 13: 40-6.
25. Moriarty P. Nanostructured materials. Rep Prog Phys. 2001; 64: 297-381.
26. Allemann E, Gurny R, Doelker E. Drug loaded nanopaticles~methods and drug targeting issues. Eur J Pharm Biopharm. 1993; 39: 173-91.
27. Cade D, Ramus E, Rinaudo M, et al. Tailoring of biocompatible polymers for elaboration of sugar-functionalized nanoparticles. Biomacromolecules. 2004; 5: 922-7.
28. Bulte JW, Kraitchman DL. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomedicine. 2004; 17: 484-99.
29. Dutz S, Wilfried A, Rudolf H, et al. Influence of dextran coating on the magnetic behaviour of iron oxide nanoparticles. J Magn Magn Mater. 2007; 311: 51-4.
30. Lawaczeck R, Menzel M, Pietsch H. Superparamagnetic iron oxide particles: contrast media for magnetic resonance imaging. Appl Organomet Chem. 2004; 18: 506-13.
31. Chemaly ER, Yoneyama R, Frangioni JV, et al. Tracking stem cells in the cardiovascular system. Trends Cardiovasc Med. 2005; 15: 297-302.
32. Lu CW, Hung Y, Hsiao JK, et al. Bifunctional magnetic silica nanoparticles for highly efficient human stem cell labeling. Nano Lett. 2007; 7: 149-54.
33. Rogers WJ, Meyer CH, Kramer CM. Technology insight: in vivo cell tracking by use of MRI. Nat Clin Pract Cardiovasc Med. 2006; 3: 554-62.
34. Gupta AK, Curtis ASG. Lactoferrin and ceruloplasmin derivatized super paramagnetic iron oxide nanoparticles for targeting cell surface receptors. Biomaterials. 2004; 25: 3029-40.
35. Emerit JC, Beaumont C, Trivin F. Iron metabolism, free radicals, and oxidative injury. Biomed Pharmacother. 2001; 55: 333-9.
36. Wang FH, Lee IH, Holmström N, et al. Magnetic resonance tracking of nanoparticle labelled neural stem cells in a rats spinal cord. Nanotechnology. 2006; 17: 1911-5.
37. Niemeyer CM, Ceyhan B. DNA-directed functionalization of colloidal gold with proteins. Angew Chem. 2001; 40: 3685-8.
38. Lewin M, Carlesso N, Tung CH. Tat peptide-deri- vatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol. 2000; 18: 410-4.
39. Bulte JW, Douglas T, Witwer B, et al. Magneto dendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol. 2001; 19: 1141-7.
40. Syková E, Jendelová P. Migration, fate and in vivo imaging of adult stem cells in the CNS. Cell Death Differ. 2007; 14: 1336-42.
41. Thorek DL, Chen AK, Czupryna J, et al. Superparamagnetic iron oxide nanoparticle probes for molecular imaging. Ann Biomed Eng. 2006; 34: 23-38.
42. Corot C, Robert P, Idée JM, et al. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliv Rev. 2006; 58: 1471-504.
43. Mahmoudi M, Hosseinkhani H, Hosseinkhani M, et al. Magnetic resonance imaging tracking of stem cells in vivo using iron oxide nanoparticles as a tool for the advancement of clinical regenerative medicine. Chem Rev. 2011; 111: 253-80.
44. Murthy N, Campbell J, Fausto N, et al. pH responsive polymeric carriers that target uptake and enhance the intracellular delivery of oligonucleotides. J Cont Rel. 2003; 89: 365-74.
45. Liu H, Webster TJ. Nanomedicine for implants: a review of studies and necessary experimental tools. Biomaterials. 2007; 2: 354-69.
46. Milane L, Ganesh S, Shah S, et al. Multi-modal strategies for overcoming tumour drug resistance: Hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology. J Cont Rel. 2011; 155: 237-47.
47. Lanza RP, Langer R, Vacanti J. Principles of Tissue Engineering (2nd ed.) San Diego: Academic Press; 2000: p. 331-50.
48. Di Maggio N, Piccinini E, Jaworski M, et al. Toward modeling the bone marrow niche using scaffold-based 3D culture systems. Biomaterials. 2011; 32: 321-9.
49. Liu H, Schmidt JJ, Bachand GD, et al. Control of a biomolecular motor-powered nanodevice with an engineered chemical switch. Nat Mater. 2002; 1: 173-7.
50. Harrison BS, Atala A. A stem cell-based tissue engineering with silk biomaterials. Biomaterials. 2007; 28: 344-53.
51. Bishnoi SW, Rozell CJ, Levin CS, et al. An all-optical nanoscale pH meter. Nano Lett. 2006; 6: 1687-92.
52. Khang D, Carpenter J, Chun YW, et al. Nanotechnology for regenerative medicine. Biomed Microdev. 2010; 12: 575-87.
53. Stevens MM, George JH. Exploring and engineering the cell surface interface. Science. 2005; 310: 1135-8.
54. Webster TJ. Nanophase ceramics as improved bone tissue engineering materials. Am Ceram Soc Bull. 2003; 82: 23-8.
55. Sato M, Webster TJ. Nanobiotechnology: implications for the future of nanotechnology in orthopaedic applications. Expert Rev Med Device. 2004; 1: 105-14.
56. Ergun C, Liu HN, Webster TJ, et al. Increased osteoblast adhesion on nanoparticulate calcium. phosphates with higher Ca/P ratios. J Biomed Mater Res Part A. 2008; 85: 236-41.
57. Webster TJ, Ergun C, Doremus RH, et al. Enhanced functions of osteoblasts on nanophase. Ceramics Biomater. 2000; 21: 1803-10.
58. Webster TJ, Siegel RW, Bizios R. Osteoblast adhesion on nanophase ceramics. Biomaterials. 1999; 20: 1221-7.
59. Yao C, Slamovich EB, Webster TJ. Enhanced osteoblast functions on anodized titanium with nanotube-like structures. J Biomed Mater Res Part A. 2008; 85A: 157-66.
60. Kay S, Thapa A, Haberstroh KM, et al. Nanostructured polymer/nanophase ceramic composites enhance osteoblast and chondrocyte adhesion. Tissue Eng. 2002; 8: 753-61.
61. Park GE, Pattison MA, Park K, et al. Accelerated chondrocyte functions on NaOH-treated PLGA scaffolds. Biomaterials. 2005; 26: 3075-82.
62. Savaiano JK, Webster TJ. Altered responses of chondrocytes to nanophase PLGA/nanophase titania composites. Biomaterials. 2004; 25: 1205-13.
63. Lu J, Rao MP, MacDonald NC, et al. Improved endothelial cell adhesion and proliferation on patterned titanium surfaces with rationally designed, micrometer to nanometer features. Acta Biomater. 2008; 4: 192-201.
64. Choudhary S, Haberstroh KM, Webster TJ. Enhanced functions of vascular cells on nanostructured Ti for improved stent applications. Tissue Eng. 2007; 13: 1421-30.
65. Miller DC, Haberstroh KM, Webster TJ. PLGA nanometer surface features manipulate fibronectin inter-actions for improved vascular cell adhesion. J Biomed Mater Res Part A. 2007; 81: 678-84.
66. McCann-Brown JA, Webster TJ, Haberstroh KM. Vascular cells respond to endothelial cell flow-and pressure-released soluble proteins. Chem Eng Commun. 2007; 194: 309-21.
67. Miller DC, Haberstroh KM, Webster TJ. Fine particles, thin films and exchange anisotropy. J Biomed Mater Res Part A. 2005; 73: 476-84.
68. Khang D, Sato M, Price RL, et al. Selective adhesion and mineral deposition by osteoblasts on carbon nanofiber patterns. Int J Nanomed. 2006; 1: 65-72.
69. Khang D, Kim SY, Liu-Snyder P, et al. Enhanced fibronectin adsorption on carbon nanotube/poly(carbonate) urethane: independent role of surface nano-roughness and associated surface energy. Biomaterials. 2007; 28: 4756-68.
70. Webster TJ, Waid MC, McKenzie JL, et al. Nano-biotechnology: carbon nanofibers as improved neural and orthopedic implants. Nanotechology. 2004; 15: 48-54.
71. Elias KL, Price RL, Webster TJ. Enhanced functions of osteoblasts on nanometer diameter carbon fibers. Biomaterials. 2002; 23: 3279-87.
72. Chun AL, Moralez JG, Fenniri H, et al. Helical rosette nanotubes: a more effective orthopaedic implant material. Nanotechnology. 2004; 15: 234-9.
73. Chun AL, Moralez JG, Webster TJ, et al. Helical rosette nanotubes: a biomimetic coating for orthopaedics. Biomaterials. 2005; 26: 7304-9.
74. Allen C, Maysinger D, Eisenberg A. Nano-engineering block copolymer aggregates for drug delivery. Colloids Surf B Biointer. 1999; 16: 3-27.
75. Langer R. Drug delivery and targeting. Nature. 1998; 392: 5-10.
76. Langer R. Perspectives: drug delivery - drugs on target. Science. 2001; 293: 58-9.
77. Svenson S, Tomalia DA. Dendrimers in biomedical applications-reflections on the field. Adv Drug Deliv Rev. 2005; 57: 2106-29.
78. Park GE, Webster TJ. A review of nanotechnology for the development of better orthopedic implants. J Biomed Nanotechnol. 2005; 1: 18-29.
79. Catledge SA, Fries MD, Vohra YK, et al. Nanostructured ceramics for biomedical implants. J Nanosci Nanotechnol. 2002; 2: 293-312.
80. Webster TJ, Ejiofor JU. Increased osteoblast adhesion on nanophase metals: Ti, Ti6Al4V, and CoCrMo. Biomaterials. 2004; 25: 4731-9.
81. Webster TJ, Hellenmeyer EL, Price RL. Increased osteoblast functions on theta +delta nanofiber alumina. Biomaterials. 2005; 26: 953-60.
82. Woo KM, Chen VJ, Ma PX. Nanofibrous scaffolding architecture selectively enhances protein adsorption contributing to cell attachment. J Biomed Mater Res A. 2003; 67: 531-7.
83. Price RL, Waid MC, Haberstroh KM, et al. Selective bone cell adhesion on formulations containing carbon nanofibers. Biomaterials. 2003; 24: 1877-87.
84. Salata OV. Applications of nanoparticles in biology and medicine. J Nanobiotechnol. 2004; 2: 3-9.
85. Heidenau F, Mittelmeier W, Detsch R, et al. A novel antibacterial titania coating: metal ion toxicity and in vitro surface colonization. J Mater Sci. 2005; 16: 883-8.
86. Zhao B, Hu H, Mandal SK, et al. A bone mimic based on the self-assembly of hydroxyapatite on single-walled carbon nanotubes. Chem Mater. 2005; 17: 3235-41.
87. Huang N, Yang P, Leng YX, et al. Hemocompatibility of titanium oxide films. Biomaterials. 2003; 24: 2177-87.
88. Chachques JC, Herreros J, Trainini J, et al. Autologous human serum for cell culture avoids the implantation of cardioverter-defibrillators in cellular cardiomyoplasty. Int J Card. 2004; 95: 29-33.
89. Stamm C, Westphal B, Kleine HD, et al. Autologous bone marrow stem-cell transplantation for myocardial regeneration. Lancet. 2003; 361: 45-6.
90. Schachinger V, Assmus B, Britten MB, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI trial. J Am Col Card. 2004; 44: 1690-9.
91. Narmoneva DA, Vukmirovic R, Davis ME, et al. Endothelial cells promote cardiac myocyte survival and spatial reorganization: implications for cardiac regeneration. Circulation. 2004; 110: 962-8.
92. Bourahla B, Shafy A, Meilhac O, et al. Mesothelial cells versus skeletal myoblasts for myocardial infarction Asi Cardiovas Thorac Ann. 2010; 18: 153-60.
93. Planat-B′enard V, Menard C, Andr′e M, et al. Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ Res. 2004; 94: 223-9.
94. Kehat I, Khimovich L, Caspi O, et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol. 2004; 22: 1282-9.
95. Chachques JC, Jorge C, et al. Myocardial assistance by grafting a new bioartificial upgraded myocardium (MAGNUM trial): clinical feasibility study. Ann Thorac Surg. 2008; 85: 901-8.
96. Schussler O, Coirault C, Tisserand ML, et al. Use of arginine-glycine-aspartic acid adhesion peptides coupled with a new collagen scaffold to engineer a myocardium-like tissue graft. Nat Clin Prac Cardiovas Med. 2009; 6: 240-9.
97. Cortes-Morichetti M, Frati G, Schussler O, et al. Association between a cell-seeded collagen matrix and cellular cardiomyoplasty for myocardial support and regeneration. Tissue Eng. 2007; 13: 2681-7.
98. Santini JT, Richards AC, Scheidt RA, et al. Microchip technology in drug delivery. Ann Med. 2000; 32: 377-9.
99. Santini JT, Cima MJ, Langer RA. controlled-release microchip. Nature. 1999; 397: 335-8.
100. LaVan DA, McGuire T, Langer R. Small-scale systems for in vivo drug delivery. Nat Biotechnol. 2003; 21: 1184-91.
101. Nicolelis MAL. Action from thoughts. Nature. 2001; 409: 403-7.
102. Nicolelis MAL. Brain-machine interfaces to restore motor function and probe neural circuits. Nat Rev Neurosci. 2003; 4: 417-22.
103. Nicolelis MAL, Chapin JK. Controlling robots with the mind. Sci Am. 2002; 287: 46-53.
104. Serruya MD, Hatsopoulos NG, Paninski L, et al. Brain-machine interface: Instant neural control of a movement signal. Nature. 2002; 416: 141-2.
105. Donoghue JP. Connecting cortex to machines: Recent advances in brain interfaces. Nat Neurosci. 2002; 5: 1085-8.
106. Schwartz AB. Cortical neural prostheses. Annu Rev Neurosci. 2004; 27: 487-507.
107. Kennedy PR, Bakay RAE, Moore MM, et al. Transactions on rehabilitation engineering. IEEE. 2000; 8: 198-202.
108. Press report of Brown University, "Pilot study of mind-to-movement device shows early promise" 2008, http://www.news-medical.net/news/2004/10/10/5440.aspx.